Contributions of Public Health in Reducing the Population Burden of Familial Hypercholesterolemia: Challenges and Opportunities
In October 2018, we attended the fifth annual Global Familial Hypercholesterolemia (FH) Summit. This gathering of more than 300 people from over 30 countries included patients, researchers, government organizations, practitioners, health systems, implementation science experts, and industry. The event focused on methods for accelerating uptake of evidence into clinical practice and health policy. The event Read More >Posted on by
Perspectives from a state genetics coordinator: Public health’s role in addressing familial hypercholesterolemia (FH) in the United States
For several years I have pondered what should or could be the state public health agency role in addressing FH. Most of my public health genetics colleagues were actively working on other CDC-labeled tier 1 conditions, such as Lynch syndrome (LS) and Hereditary Breast and Ovarian Cancer syndrome (HBOC). While few, if any, of my Read More >Posted on by
Advances in genomics, bioinformatics and other technologies are ushering a new era of precision medicine and precision public health. Human genome sequencing is increasingly used in a variety of health systems in the United States and globally. Pathogen genomic sequencing is been rapidly integrated into clinical and public health research and practice. 2018 marked 20 Read More >Posted on by
Introducing GRANTOMICS: Our enhanced search engine and analysis tool for grant information associated with publications on genomics and population health impact.
The CDC Office of Public Health Genomics has launched GRANTOMICS, an extension of the Public Health Genomics Knowledge Base (PHGKB). GRANTOMICS is an upgraded version of the Grant Database, introduced in March, 2018, and reviewed in a previous blog. The upgraded GRANTOMICS database allows you to: Perform searches with any free text word or term, Read More >Posted on by